These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21809803)

  • 1. CMV vaccine shows impressive control in nonhuman primates.
    IAVI Rep; 2011; 15(3):19. PubMed ID: 21809803
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus vaccines: current status.
    Starr SE
    Infect Agents Dis; 1992 Jun; 1(3):146-8. PubMed ID: 1365538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could a vaccine against immune-evading cytomegalovirus become a reality?
    Emery VC
    Expert Rev Vaccines; 2011 Aug; 10(8):1109-11. PubMed ID: 21854303
    [No Abstract]   [Full Text] [Related]  

  • 4. CMV superinfection no longer shrouded in mystery.
    von Bubnoff A
    IAVI Rep; 2010; 14(2):17. PubMed ID: 20496661
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress toward developing a cytomegalovirus vaccine.
    Marshall GS; Plotkin SA
    Infect Dis Clin North Am; 1990 Jun; 4(2):283-98. PubMed ID: 2161034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trends in research in developing new type of vaccines--aiming at efficacy and safety. Cytomegalovirus vaccine].
    Furukawa T
    Nihon Rinsho; 1987 Oct; 45(10):2421-6. PubMed ID: 2834581
    [No Abstract]   [Full Text] [Related]  

  • 7. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
    Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z
    J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMV vaccine: a response to criticism.
    Plotkin SA
    Hosp Pract; 1978 Sep; 13(9):18, 24. PubMed ID: 213369
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA vaccines against cytomegalovirus: current progress.
    Temperton NJ
    Int J Antimicrob Agents; 2002 Mar; 19(3):169-72. PubMed ID: 11932137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMV-based vaccine elicits a new kind of T-cell response in macaques.
    von Bubnoff A
    IAVI Rep; 2013; 17(2):19. PubMed ID: 23847820
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization strategy for prevention of congenital cytomegalovirus infection.
    Pass RF
    Infect Agents Dis; 1996 Oct; 5(4):240-4. PubMed ID: 8884369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine.
    Frey SE; Harrison C; Pass RF; Yang E; Boken D; Sekulovich RE; Percell S; Izu AE; Hirabayashi S; Burke RL; Duliège AM
    J Infect Dis; 1999 Nov; 180(5):1700-3. PubMed ID: 10515836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant.
    Pass RF; Duliegè AM; Boppana S; Sekulovich R; Percell S; Britt W; Burke RL
    J Infect Dis; 1999 Oct; 180(4):970-5. PubMed ID: 10479120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients.
    Plotkin SA; Higgins R; Kurtz JB; Morris PJ; Campbell DA; Shope TC; Spector SA; Dankner WM
    Transplantation; 1994 Dec; 58(11):1176-8. PubMed ID: 7992358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against human cytomegalovirus with live virus.
    Plotkin SA; Friedman HM; Starr S; Fleisher G
    Dev Biol Stand; 1982; 52():373-9. PubMed ID: 6299846
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of cytomegalovirus disease by Towne strain live attenuated vaccine.
    Plotkin SA; Smiley ML; Friedman HM; Starr SE; Fleisher GR; Wlodaver C; Dafoe DC; Friedman AD; Grossman RA; Barker CF
    Birth Defects Orig Artic Ser; 1984; 20(1):271-87. PubMed ID: 6329367
    [No Abstract]   [Full Text] [Related]  

  • 17. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.
    Bourne N; Schleiss MR; Bravo FJ; Bernstein DI
    J Infect Dis; 2001 Jan; 183(1):59-64. PubMed ID: 11087203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMV-based vaccine candidate protects macaques from systemic infection.
    von Bubnoff A
    IAVI Rep; 2009; 13(2):18. PubMed ID: 20214311
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of cytomegalovirus disease in renal allograft recipients.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():88-93. PubMed ID: 1725064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of cytomegalovirus infections in renal transplants].
    Rondeau E; Peraldi MN; Kanfer A; Sraer JD
    Nephrologie; 1991; 12(4):189-92. PubMed ID: 1660570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.